A Headache for Small Drug Makers
1011
The F.D.A. has begun to crack down on the thousands of drugs, often made by small companies, that have never had to go through the agencyâs stringent approval process.
112421
The medical profession has a costly, little-known secret: Many treatments don&#39;t work all that well for many -- even most -- people.
21611
One undervalued drug developer may be on the cusp of greatness.
727152
New developments are brewing at the pharmaceutical.
356446
A new study indicates that instructions and warnings on medication bottles tend to be in smaller type and warnings smaller still.
673670
Bristol-Myers Squibb struggles to keep growing amid patent expirations.
591115
A one-drug wonder doesn't have a future.
494627
An interview with development-stage drugmaker Pharmacopeia.
271921
The reduction in patients for Amylin's Byetta diabetes drug could be small.
23412
A new program to provide low-cost drugs to people with cancer and other serious illnesses has fallen far short of expectations.
161495
Progress on its lead drug remains stalled.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
436402
Charging workersâ out-of-pocket costs for medicines may be more than offset by reduced productivity, study finds.
29666
While treatments have multiplied, the operations and processes for delivering those medicines haven't kept pace, slowing health improvement in developing and developed countries. Alexis Madrigal reports from the AAAS annual meeting in Boston.
236669
With yet more already-marketed medicines raising the ire of consumer advocates and regulators alike, momentum is building for reform of the governmentâs drug approval and monitoring procedures.
399867
Importing cheaper prescription  medicines would require costly safety measures and save U.S.  consumers little money, a government task force said on Tuesday  in a report that lawmakers and others criticized as echoing  drug industry scare tactics.
422409
The flu vaccine is not the only vaccine that Americans could find in short supply due to a lack of enough manufacturing facilities licensed by the US Food and Drug Administration.